113 related articles for article (PubMed ID: 27829177)
1. A naturally occurring variant of HPV-16 E7 exerts increased transforming activity through acquisition of an additional phospho-acceptor site.
Zine El Abidine A; Tomaić V; Bel Haj Rhouma R; Massimi P; Guizani I; Boubaker S; Ennaifer E; Banks L
Virology; 2017 Jan; 500():218-225. PubMed ID: 27829177
[TBL] [Abstract][Full Text] [Related]
2. HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner.
Rabachini T; Boccardo E; Andrade R; Perez KR; Nonogaki S; Cuccovia IM; Villa LL
BMC Cancer; 2018 Apr; 18(1):485. PubMed ID: 29703186
[TBL] [Abstract][Full Text] [Related]
3. The canine papillomavirus and gamma HPV E7 proteins use an alternative domain to bind and destabilize the retinoblastoma protein.
Wang J; Zhou D; Prabhu A; Schlegel R; Yuan H
PLoS Pathog; 2010 Sep; 6(9):e1001089. PubMed ID: 20824099
[TBL] [Abstract][Full Text] [Related]
4. Cysteine-rich positions outside the structural zinc motif of human papillomavirus E7 provide conformational modulation and suggest functional redox roles.
Chemes LB; Camporeale G; Sánchez IE; de Prat-Gay G; Alonso LG
Biochemistry; 2014 Mar; 53(10):1680-96. PubMed ID: 24559112
[TBL] [Abstract][Full Text] [Related]
5. Disruption of pocket protein dream complexes by E7 proteins of different types of human papillomaviruses.
Nor Rashid N; Yusof R; Watson RJ
Acta Virol; 2013; 57(4):447-51. PubMed ID: 24294959
[TBL] [Abstract][Full Text] [Related]
6. Phylogenetic and functional analysis of sequence variation of human papillomavirus type 31 E6 and E7 oncoproteins.
Ferenczi A; Gyöngyösi E; Szalmás A; László B; Kónya J; Veress G
Infect Genet Evol; 2016 Sep; 43():94-100. PubMed ID: 27197052
[TBL] [Abstract][Full Text] [Related]
7. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7.
Gonzalez SL; Stremlau M; He X; Basile JR; Münger K
J Virol; 2001 Aug; 75(16):7583-91. PubMed ID: 11462030
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
9. Human papilloma virus (HPV) E7-mediated attenuation of retinoblastoma (Rb) induces hPygopus2 expression via Elf-1 in cervical cancer.
Tzenov YR; Andrews PG; Voisey K; Popadiuk P; Xiong J; Popadiuk C; Kao KR
Mol Cancer Res; 2013 Jan; 11(1):19-30. PubMed ID: 23284001
[TBL] [Abstract][Full Text] [Related]
10. Novel effect of the high risk-HPV E7 CKII phospho-acceptor site on polarity protein expression.
Dizanzo MP; Bugnon Valdano M; Basukala O; Banks L; Gardiol D
BMC Cancer; 2022 Sep; 22(1):1015. PubMed ID: 36153517
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity.
Massimi P; Pim D; Banks L
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2607-13. PubMed ID: 9349482
[TBL] [Abstract][Full Text] [Related]
12. HPV 16E7 and 48E7 proteins use different mechanisms to target p130 to overcome cell cycle block.
Nor Rashid N; Yong ZL; Yusof R; Watson RJ
Virol J; 2016 Jan; 13():2. PubMed ID: 26728921
[TBL] [Abstract][Full Text] [Related]
13. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE
J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029
[TBL] [Abstract][Full Text] [Related]
14. HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation.
Massimi P; Pim D; Storey A; Banks L
Oncogene; 1996 Jun; 12(11):2325-30. PubMed ID: 8649772
[TBL] [Abstract][Full Text] [Related]
15. High-Risk Human Papillomavirus E7 Proteins Target PTPN14 for Degradation.
White EA; Münger K; Howley PM
mBio; 2016 Sep; 7(5):. PubMed ID: 27651363
[TBL] [Abstract][Full Text] [Related]
16. Retinoblastoma-independent antiproliferative activity of novel intracellular antibodies against the E7 oncoprotein in HPV 16-positive cells.
Accardi L; Donà MG; Mileo AM; Paggi MG; Federico A; Torreri P; Petrucci TC; Accardi R; Pim D; Tommasino M; Banks L; Chirullo B; Giorgi C
BMC Cancer; 2011 Jan; 11():17. PubMed ID: 21241471
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of the gamma human papillomavirus type 197 E6 and E7 associated cellular proteins.
Grace M; Munger K
Virology; 2017 Jan; 500():71-81. PubMed ID: 27771561
[TBL] [Abstract][Full Text] [Related]
18. The Rb binding domain of HPV31 E7 is required to maintain high levels of DNA repair factors in infected cells.
Johnson BA; Aloor HL; Moody CA
Virology; 2017 Jan; 500():22-34. PubMed ID: 27770701
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor.
Huh K; Zhou X; Hayakawa H; Cho JY; Libermann TA; Jin J; Harper JW; Munger K
J Virol; 2007 Sep; 81(18):9737-47. PubMed ID: 17609271
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccine encoding HPV-16 E7 with mutation in L-Y-C-Y-E pRb-binding motif induces potent anti-tumor responses in mice.
Bahrami AA; Ghaemi A; Tabarraei A; Sajadian A; Gorji A; Soleimanjahi H
J Virol Methods; 2014 Sep; 206():12-8. PubMed ID: 24880067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
